Data / Federal rules / 2024-11229
Labeling Requirements for Approved or Conditionally Approved New Animal Drugs; Extension of Comment Period
The Food and Drug Administration published this proposed rule in the Federal Register on May 22, 2024. Comments closed on August 9, 2024.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule entitled "Labeling Requirements for Approved or Conditionally Approved New Animal Drugs" published in the Federal Register of March 12, 2024, by 60 days. The Agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.
Key facts
- Document number
- 2024-11229
- Type
- Proposed rule
- Action
- Proposed rule; extension of comment period
- Agency
- Health and Human Services Department; Food and Drug Administration
- Published
- May 22, 2024
- Comments due
- August 9, 2024
- Dates
- FDA is extending the comment period on the proposed rule published March 12, 2024 (89 FR 18262), by 60 days. Either electronic or written comments must be submitted by August 9, 2024.
- Docket
- Docket No. FDA-2023-N-5160
- Regulation ID (RIN)
- 0910-AI43
- Code of Federal Regulations
- 21 CFR 201; 21 CFR 500; 21 CFR 501; 21 CFR 510; 21 CFR 514; 21 CFR 516
- Pages
- 2
Other documents from the Food and Drug Administration
Everything from the Food and Drug Administration · Published in May 2024
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.